Patents by Inventor Annick Ocmant

Annick Ocmant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for evaluating the response of an individual to a treatment with a type I interferon (IFN)
    Patent number: 8426170
    Abstract: A method for evaluating the in vivo presence of a factor that prevents the biological effect of a type I (IFN) in an individual that is under treatment with type I interferon is described. The in vivo presence of antibodies directed against a type I interferon (IFN) is evaluated in an individual that is under treatment with type I interferon. The method includes incubating a blood sample of the individual in vitro with a suitable amount of the type I interferon for a suitable period of time, and determining mRNA levels of a biological marker of IFN activity, preferably MxA, in the blood sample. The treatment may involve a treatment of multiple sclerosis, HCV or HBV using a type I interferon.
    Type: Grant
    Filed: January 24, 2008
    Date of Patent: April 23, 2013
    Assignee: Universite Libre de Bruxelles
    Inventors: Patrick Stordeur, Mathieu Vokaer, Annick Ocmant, Michel Goldman
  • MARKER FOR DIAGNOSIS OF ACTIVE MULTIPLE SCLEROSIS
    Publication number: 20120190031
    Abstract: The invention provides an improved method for monitoring the course of the MS disease and to predict, diagnose or prognosticate whether a subject is in an active or non-active period of MS. The method is based on determining the ratio of the expression levels of two cytokines, measured before and after stimulation of the subject by an immunomodulator.
    Type: Application
    Filed: March 25, 2010
    Publication date: July 26, 2012
    Applicant: UNIVERSITÉ LIBRE DE BRUXELLES
    Inventors: Patrick Stordeur, Françoise Villée, Mathieu Vokaer, Annick Ocmant, Michel Goldman
  • METHOD FOR EVALUATING THE RESPONSE OF AN INDIVIDUAL TO A TREATMENT WITH A TYPE I INTERFERON (IFN)
    Publication number: 20100129788
    Abstract: A method for evaluating the in vivo presence of a factor that prevents the biological effect of a type I (IFN) in an individual that is under treatment with type I interferon is described. The in vivo presence of antibodies directed against a type I interferon (IFN) is evaluated in an individual that is under treatment with type I interferon. The method includes incubating a blood sample of the individual in vitro with a suitable amount of the type I interferon for a suitable period of time, and determining mRNA levels of a biological marker of IFN activity, preferably M×A, in the blood sample. The treatment may involve a treatment of multiple sclerosis, HCV or HBV using a type I interferon.
    Type: Application
    Filed: January 24, 2008
    Publication date: May 27, 2010
    Applicant: Universite Libre de Bruxelles
    Inventors: Patrick Stordeur, Mathieu Vokaer, Annick Ocmant, Michel Goldman
  • Method for Detecting Anti-Transglutaminase Antibodies
    Publication number: 20080038760
    Abstract: Methods for detecting anti-transglutaminase antibodies in a saliva sample containing the antibodies are disclosed. Saliva samples are pre-treated. The antibodies are subsequently detected in the pre-treated saliva by an immune reaction with a transglutaminase under conditions suitable for forming immuno-complexes with the antibodies. The method is useful for diagnosing and/or therapeutically controlling celiac disease.
    Type: Application
    Filed: June 6, 2005
    Publication date: February 14, 2008
    Inventors: Francoise Mascart, Annick Ocmant